This week’s funding activity underscores how MedTech innovation is expanding beyond devices alone, with investors backing integrated platforms spanning therapeutics, diagnostics, biomaterials, and intelligent sensing.
Senseonics announces $80M public offering
Senseonics announced that it commenced an...
This week’s funding activity underscores how MedTech innovation is expanding beyond devices alone, with investors backing integrated platforms spanning therapeutics, diagnostics, biomaterials, and intelligent...
US company Xtant Medical Holdings has commercially launched the Trivium Shaped allograft, a new addition to its Trivium bone graft range for surgical use.
The...
Roche has signed a definitive merger agreement for the acquisition of US-based PathAI in a deal valued at up to $1.05bn.
PathAI specialises in digital...
Resmed has entered into a definitive merger agreement to acquire Noctrix Health for $340 million, according to Noctrix investor Treo Ventures.
Resmed CEO Mick Farrell...
Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study.
REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...
CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy.
Barostim delivers electrical pulses to baroreceptors in the...
Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system.
Findings published in the Journal of Neurointerventional...
CorTec GmbH announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled...
This week’s funding activity underscores how MedTech innovation is expanding beyond devices alone, with investors backing integrated platforms spanning therapeutics, diagnostics, biomaterials, and intelligent...
US company Xtant Medical Holdings has commercially launched the Trivium Shaped allograft, a new addition to its Trivium bone graft range for surgical use.
The...
Roche has signed a definitive merger agreement for the acquisition of US-based PathAI in a deal valued at up to $1.05bn.
PathAI specialises in digital...
Resmed has entered into a definitive merger agreement to acquire Noctrix Health for $340 million, according to Noctrix investor Treo Ventures.
Resmed CEO Mick Farrell...